Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Marinus Pharmaceuticals (MRNS) PT Raised to $24.50 at Ladenburg Thalmann
March 6, 2019 1:35 PM ESTLadenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $24.50 (from $22.00) while maintaining a Buy rating.
... More